The purification of EPO, the cloning of its gene, and subsequent development of recombinant EPO (rEPO) revolutionized the treatment of anemia associated with EPO deficiency (Egrie, 1990; Lin et al., 1985; Sinclair, 2013). The gene discussed is EPO; the disease is hyperinsulinemic hypoglycemia, familial, 4.